Use of a flow‐cell system to investigate virucidal dimethylmethylene blue phototreatment in two RBC additive solutions
- 16 September 2002
- journal article
- Published by Wiley in Transfusion
- Vol. 42 (9) , 1200-1205
- https://doi.org/10.1046/j.1537-2995.2002.00163.x
Abstract
BACKGROUND: Limited photoinactivation kinetics, use of low‐volume 30 percent Hct RBCs, and hemolysis have restricted the practicality of the use of dimethylmethylene blue (DMMB) and light for RBC decontamination. A flow‐cell system was developed to rapidly treat larger volumes of oxygenated 45 percent Hct RBCs with high‐intensity red light.MATERIALS AND METHODS: CPD‐whole blood was WBC reduced, RBCs were diluted in additive solutions (either Adsol or Erythrosol), and suspensions were subsequently oxygenated by gas overlay. Intracellular or extracellular VSV and DMMB were sequentially added. VSV‐infected RBC suspensions (45% Hct) were passed through 1‐mm‐thick flow cells and illuminated. Samples were titered for VSV, stored for up to 42 days, and assayed for Hb, supernatant potassium, ATP, and MCV.RESULTS: The use of oxygenated RBCs resulted in rapid and reproducible photoinactivaton of ≥6.6 log extracellular and approximately 4.0 log intracellular VSV independent of additive solution. Phototreated Adsol RBCs exhibited more than 10 times greater hemolysis and 30 percent greater MCV during storage than identically treated Erythrosol RBCs. Phototreatment caused RBC potassium leakage from RBCs in both additive solutions. ATP levels were better preserved in Erythrosol than Adsol RBCs.CONCLUSION: A rapid, reproducible, and robust method for photoinactivating model virus in RBC suspensions was developed. Despite improved hemolysis and ATP levels in Erythrosol‐phototreated RBCs, storage properties were not maintained for 42 days.Keywords
This publication has 20 references indexed in Scilit:
- Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor populationTransfusion, 2002
- Clinical and Laboratory Experience with Erythrocyte and Platelet Preparations from a 0.5CPD Erythro‐Sol Opti SystemVox Sanguinis, 1997
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamoleFree Radical Biology & Medicine, 1995
- Half-Strength Citrate CPD Combined with a New Additive Solution for Improved Storage of Red Blood Cells Suitable for Clinical UseVox Sanguinis, 1993
- Manipulating Red Cell Intra- and Extracellular pH by WashingVox Sanguinis, 1991
- Refrigerated Storage of Washed Red CellsVox Sanguinis, 1991
- The kinetics of colloid osmotic hemolysis. II. PhotohemolysisBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- Ionic and osmotic equilibria of human red blood cells treated with nystatin.The Journal of general physiology, 1979
- Anion transport in relation to proteolytic dissection of band 3 proteinBiochimica et Biophysica Acta (BBA) - Biomembranes, 1978